High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer
Autor: | Braunschweig, I., Mirza, N.Q., Rondon, G., Lauppe, J., Mehra, R., Gajewski, J., Korbling, M., Huh, Y.O., Geisler, D., Gee, A.P., Champlin, R., Przepiorka, D. |
---|---|
Zdroj: | In Cytotherapy February 2000 2(2):105-110 |
Databáze: | ScienceDirect |
Externí odkaz: |